AHA, Others Urge HHS to Protect 340B Hospitals from Drug Companies Trying to Undermine Program

On behalf of the nation’s 340B hospitals, AHA, others urge the Department of Health and Human Services (HHS) to protect vulnerable communities from actions taken by five of the nation’s largest pharmaceutical manufacturers that undermine access to critical drugs and other health care services. We ask the HHS to use its authority to require that these and other pharmaceutical manufacturers comply with the law. This is particularly critical now as these hospitals need every resource available to care for their patients in vulnerable communities during the COVID-19 public health crisis.

Related Resources

Podcasts
Member
On-demand Podcast COVID-19 Safety and the Road to COVID-19 Recovery: The Role of the Board Governance expert Jamie Orlikoff and James Reinertsen, M.D.,…
Podcasts
Member
On-demand Podcast COVID-19 Governance in the Time of Coronavirus: What governing boards should do to respond to the pandemic As hospitals and health…
Special Bulletin
Public
The AHA today urged the Department of Health and Human Services to reinstate the COVID-19 Provider Relief Fund reporting requirements outlined in its June 19…
Letter/Comment
Public
The American Hospital Association asks the Secretary of Health and Human Services (HHS) to reinstate the COVID-19 Provider Relief Fund (PRF) reporting…
Leadership Rounds
AHA Board Chair Melinda Estes, M.D., hosts a series of Leadership Rounds — short conversations on a range of key issues Dr. Estes will have with hospital…
Other Resources
Photo credit: @UNMC_ID It’s too soon now to know what kind of impact living through the COVID-19 pandemic will have on children. But the dedication and…